Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Natural history of AATD in adults – not only COPD Paweł Kuca Warsaw, 17-10-2015 Introduction (1) Clinical presentations that may be consistent with AATD Emphysema - early onset, no smoking, basilar predominance, family history Other lung disease - bronchiectasis of unclear etiology Liver disease Other - necrotizing panniculitis - anti-proteinase 3-positive vasculitis (C-ANCA) Introduction (2) • • • • Asthma Bronchiectasis Lung cancer COPD-associated cardiovascular risk Asthma • Asthma in patients with AATD • Reversibility/ BHR in patients with AATD • AAT in patients with asthma Bronchiectasis • Bronchiectasis in patients with AATD • AATD in patients with bronchiectasis Figure 3. Top: Lower zone image (at the level of the inferior pulmonary veins) from a subject with severe cystic bronchiectasis and mild emphysema. Bottom: Quantitative analysis of emphysema, with the low-density voxels highlighted in pink (Pulmo-CMS; Medis Medical Imaging Systems). Lung cancer • AATD status and lung cancer risk • Emphysema as risk factor for lung cancer • AATD in advanced lung cancer COPD-associated cardiovascular risk • AAT and cardiovascular risk in population • AATD and aortic stiffness • AATD and systemic inflammation General conclusions (1) • Q1: Does suboptimal AAT status predispose to other lung diseases? • Yes, - asthma, - bronchiectasis, - lung cancer etc. General conclusions (2) • Q 2: Is the list of AATD-related lung diseases now closed? • No ! - TB, NTM-infections, - idiopathic pulmonary fibrosis, - pneumothorax, - pulmonary vasculitis etc. Natural history of AATD in adults - AATD related lung disease (airways remodeling, parenchyma destruction - radiological and functional evidence) end stage phase chronic systemic inflammation exacerbations colonisation (Pseudomonas, NTM) RF (blue blotter), RHF, RF (pink puffer), lung cancer cardiovascular risk (MI, stroke) late phase asthma (no radiological signs, functional reversibility) smoking/ infections chronic bronchitis, bronchiectasis, emphysema early phase AATD status